Examination of searching about the association between cerebrum, hippocampal atrophy / cerebral ischemic lesion and various atherosclerotic parameters in the chronic kidney disease patient

Examination of searching about the association between cerebrum, hippocampal atrophy / cerebral ischemic lesion and various atherosclerotic parameters in the chronic kidney disease patient - Study on the CKD and relations of cerebral ischemia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021180

Enrollment

Registered

2016-02-24

Start date

2015-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease (Stage I-IV)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The CKD patient who visiting our outpatient unit of nephrology will have been administrated and agreed to examine brain MRI and brain blood flow scintigraphy from December, 2015 to December, 2018

Exclusion criteria

Exclusion criteria: The past history of the stroke or person with the paralysis (aftereffects) Patient in acknowledgment of old infarction or cerebral hemorrhage that was clear by a brain MRI images. The patient who cannot do the examination of cognitive function by visual impairment, a hearing loss or mental instability Patient who cannot secure of intravenous line on the right arms (after operation of breast cancer) Patient with thyroid disease The patient who takes a sleep agent, regularly iodoallergy The patient who have an MRI taboo (e.g. the pacemaker insertion, claustrophobia), a study person will judge to be inappropriate as a study subject

Design outcomes

Primary

Measure	Time frame
Evaluation of the cerebrum, the hippocampal atrophy ratio by VSRAD Evaluation of the brain blood flow by the SPECT (123I-IMP)	—

Secondary

Measure	Time frame
An inspection about the item and anamnesis, relations with drugs to reflect an arteriosclerosis-related parameters Difference in brain blood flow, brain atrophy in each CKD stage	—

Countries

Japan

Contacts

Public ContactKyoko Maesato

Shonan Kamakura General Hospital Department of Nephrology, Immunology, and Vascular Medicine

kyoko.maesato@tokushukai.jp+81-467-461717

Outcome results